Divozilimab Biosimilar - Research Grade

Human

MS4A1ï؟½

5mg/ml

IgG1 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

P11836

Blue ice

A cornerstone target across lymphoma and autoimmunity research, MS4A1 (CD20) is a B-cell-surface protein integral to B-lymphocyte biology. As an unconjugated, non-therapeutic analog of divozilimab, this human IgG1-kappa recombinant antibody is supplied for research use only. It is formulated low in endotoxin to in vivo standards and manufactured in scalable milligram-to-gram quantities for high-throughput laboratories. Researchers apply it to functional assays, B-cell depletion and ADCC studies, in vitro screening and preclinical models that investigate CD20-directed approaches, with consistent performance over time. Built for in vivo use with low endotoxin and scalable milligram-to-gram supply, it remains a reliable choice for bulk research applications.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks